Here are my slides from Open Innovation in Action. The conference was held at the UK’s first biomedical open innovation campus, Stevenage Bioscience Catalyst (SBC), where I’m currently advising on open innovation strategy.
As the presenter tasked with opening the conference, I had two simple objectives – giving a definition of open innovation, and sharing some thoughts on what the future holds for open innovation in the bioscience sector.
Given that the average drug takes 15 years of R&D and $1billion to develop, this sector has very extreme challenges. This in turn means that the use of open innovation holds much promise for providing affordable medicines from stable businesses, but there are also sector-wide obstacles in terms of culture change, IP, traditional business models and more. But the conference really emphasised for me that the sector is ready and willing to use open innovation in a collaborative way and make it work.
The other speakers were an impressive collection of experts from biotech, pharma, and other sectors. There were two excellent keynote speakers – Stefan Lindegaard, the open innovation expert and author, and Patrick Vallance, President of Pharmaceuticals R&D at GlaxoSmithKline. You can see slides from every speaker on SBC’s webpage for the event.
I’ve already posted some of my favourite quotes from the day. My slides are usually quite visual rather than explaining everything with words, so rather than simply embedding the images here I’m providing the slideshare link so you can also read the notes for each slide. Go to http://tinyurl.com/crva6up
You might like to share this post: